Market Overview:
The global longevity and anti-senescence therapy market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of age-related diseases, rising geriatric population, and technological advancements in the field of longevity and anti-senescence therapies. The global longevity and anti-senescence therapy market is segmented on the basis of type into hemolytic drug therapy, gene therapy, immunotherapy, and other stem cell therapies. Hemolytic drug therapy is expected to account for the largest share of the global longevity and anti-senescence therapy market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to its ability to improve red blood cell function by reducing oxidative stress levels. Gene Therapy is expected grow at highest rate over next decade owing high potential benefits associated with it which are repairing or replacing defective genes that cause disease or disability; correcting genetic disorders; treating cancer; slowing aging process etc., Immunotherapy also has potential benefits such as stimulation & activation immune cells which helps fight infections & tumors etc.
Product Definition:
Longevity refers to the length of time a particular species can live and produce offspring. Anti-senescence therapy is a type of treatment that slows or reverses the effects of aging. The importance of longevity and anti-senescence therapy is that it can help extend the life of an individual, which in turn can lead to increased productivity and a longer period in which an individual can contribute to society.
Hemolytic Drug Therapy:
Hemolytic drug therapy is a group of drugs and techniques that destroy red blood cells (RBCs), causing anemia. The destruction of RBCs causes the body to produce more hemoglobin, which leads to increased oxygen delivery to tissues and improved ability to carry oxygenated blood throughout the body.
Gene Therapy:
Gene therapy is a new and innovative medical technology that involves the use of DNA as a therapeutic agent for treating genetic diseases. It works by restoring or repairing the damaged genes in cells. The basic principle behind this technology is that defective genes can be replaced with functional ones, which are usually found in viruses or bacteria.
Application Insights:
The global market is segmented by application into hospital, medical service institution and drug and device sales. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as a large patient base with unmet needs, high prevalence of chronic diseases that require long-term care, increasing geriatric population and an increase in number of hospitals due to rapid urbanization.
Medical service institutions are anticipated to witness lucrative growth over the forecast period owing to factors such as aging population with multiple chronic conditions; rising incidences of cancer; technological advancements that have increased accessibility for patients at an early stage; growing emphasis on stem cell research for regenerative medicine which has resulted in new treatment modalities for anti-senescence therapy along with other treatments including chemotherapy and radiation therapy; increasing adoption due to favorable reimbursement policies followed by countries such as Japan which funds most or all of the cost associated with these therapies thereby driving demand globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large geriatric population and high adoption of these therapies are some factors contributing to its growth. Moreover, the availability of supportive infrastructure such as research facilities and favorable reimbursement policies are expected to drive the regional market over the forecast period. Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing geriatric population, rising healthcare expenditure, growing awareness about advanced therapies for aging-related diseases, and improving economic conditions in emerging countries such as China & India & South Korea etcetera.
Moreover, an increase in government initiatives for developing stem cell therapy products is also expected favorably impact overall industry development during this period (2018 - 2030).
Growth Factors:
- Rising geriatric population: The global geriatric population is expected to grow at a CAGR of 6.5% from 2016 to 2020, reaching 1.6 billion by 2020. This growing population is increasingly susceptible to age-related health problems, such as cancer, heart disease, and Alzheimer’s disease, which are the leading causes of death in the elderly. This provides a large potential patient pool for therapies that target longevity and anti-senescence therapy market growth.
- Advances in technology: Technological advances have led to the development of novel therapies that target longevity and anti-senescence pathways. These advances are likely to continue driving market growth over the forecast period as they enable researchers to develop new treatments for age-related diseases and improve existing treatments options available in the market place .
Scope Of The Report
Report Attributes
Report Details
Report Title
Longevity and Anti-senescence Therapy Market Research Report
By Type
Hemolytic Drug Therapy, Gene Therapy, Immunotherapy, Other Stem Cell Therapies
By Application
Hospital, Medical Service Institution, Drug and Device Sales
By Companies
CohBar, TA Sciences, Unity Biotechnology, AgeX Therapeutics，Inc, PowerVision Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Longevity and Anti-senescence Therapy Market Report Segments:
The global Longevity and Anti-senescence Therapy market is segmented on the basis of:
Types
Hemolytic Drug Therapy, Gene Therapy, Immunotherapy, Other Stem Cell Therapies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical Service Institution, Drug and Device Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CohBar
- TA Sciences
- Unity Biotechnology
- AgeX Therapeutics，Inc
- PowerVision Inc.
Highlights of The Longevity and Anti-senescence Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hemolytic Drug Therapy
- Gene Therapy
- Immunotherapy
- Other Stem Cell Therapies
- By Application:
- Hospital
- Medical Service Institution
- Drug and Device Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Longevity and Anti-senescence Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Longevity and anti-senescence therapy is a field of research that investigates the potential to extend life by preventing or reversing age-related diseases.
Some of the key players operating in the longevity and anti-senescence therapy market are CohBar, TA Sciences, Unity Biotechnology, AgeX Therapeutics，Inc, PowerVision Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Longevity and Anti-senescence Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Longevity and Anti-senescence Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Longevity and Anti-senescence Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Longevity and Anti-senescence Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Longevity and Anti-senescence Therapy Market Size & Forecast, 2018-2028
4.5.1 Longevity and Anti-senescence Therapy Market Size and Y-o-Y Growth
4.5.2 Longevity and Anti-senescence Therapy Market Absolute $ Opportunity
Chapter 5 Global Longevity and Anti-senescence Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Longevity and Anti-senescence Therapy Market Size Forecast by Type
5.2.1 Hemolytic Drug Therapy
5.2.2 Gene Therapy
5.2.3 Immunotherapy
5.2.4 Other Stem Cell Therapies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Longevity and Anti-senescence Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Longevity and Anti-senescence Therapy Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Medical Service Institution
6.2.3 Drug and Device Sales
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Longevity and Anti-senescence Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Longevity and Anti-senescence Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Longevity and Anti-senescence Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Longevity and Anti-senescence Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Longevity and Anti-senescence Therapy Market Size Forecast by Type
9.6.1 Hemolytic Drug Therapy
9.6.2 Gene Therapy
9.6.3 Immunotherapy
9.6.4 Other Stem Cell Therapies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Longevity and Anti-senescence Therapy Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Medical Service Institution
9.10.3 Drug and Device Sales
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Longevity and Anti-senescence Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Longevity and Anti-senescence Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Longevity and Anti-senescence Therapy Market Size Forecast by Type
10.6.1 Hemolytic Drug Therapy
10.6.2 Gene Therapy
10.6.3 Immunotherapy
10.6.4 Other Stem Cell Therapies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Longevity and Anti-senescence Therapy Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Medical Service Institution
10.10.3 Drug and Device Sales
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Longevity and Anti-senescence Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Longevity and Anti-senescence Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Longevity and Anti-senescence Therapy Market Size Forecast by Type
11.6.1 Hemolytic Drug Therapy
11.6.2 Gene Therapy
11.6.3 Immunotherapy
11.6.4 Other Stem Cell Therapies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Longevity and Anti-senescence Therapy Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Medical Service Institution
11.10.3 Drug and Device Sales
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Longevity and Anti-senescence Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Longevity and Anti-senescence Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Longevity and Anti-senescence Therapy Market Size Forecast by Type
12.6.1 Hemolytic Drug Therapy
12.6.2 Gene Therapy
12.6.3 Immunotherapy
12.6.4 Other Stem Cell Therapies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Longevity and Anti-senescence Therapy Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Medical Service Institution
12.10.3 Drug and Device Sales
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Longevity and Anti-senescence Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Longevity and Anti-senescence Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Longevity and Anti-senescence Therapy Market Size Forecast by Type
13.6.1 Hemolytic Drug Therapy
13.6.2 Gene Therapy
13.6.3 Immunotherapy
13.6.4 Other Stem Cell Therapies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Longevity and Anti-senescence Therapy Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Medical Service Institution
13.10.3 Drug and Device Sales
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Longevity and Anti-senescence Therapy Market: Competitive Dashboard
14.2 Global Longevity and Anti-senescence Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CohBar
14.3.2 TA Sciences
14.3.3 Unity Biotechnology
14.3.4 AgeX Therapeutics，Inc
14.3.5 PowerVision Inc.
